159 related articles for article (PubMed ID: 31664423)
1. Prediabetes and Type 2 Diabetes are Independent Risk Factors for Computed Tomography-Estimated Nonalcoholic Fatty Pancreas Disease.
Ahbab S; Ünsal A; Ataoğlu HE; Can TS; Kayaş D; Savaş Y
Clinics (Sao Paulo); 2019; 74():e1337. PubMed ID: 31664423
[TBL] [Abstract][Full Text] [Related]
2. The association between nonalcoholic fatty pancreas disease and diabetes.
Ou HY; Wang CY; Yang YC; Chen MF; Chang CJ
PLoS One; 2013; 8(5):e62561. PubMed ID: 23671610
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.
Filippatos TD; Alexakis K; Mavrikaki V; Mikhailidis DP
Dig Dis Sci; 2022 Jan; 67(1):26-41. PubMed ID: 33469809
[TBL] [Abstract][Full Text] [Related]
4. Lack of Independent Association Between Fatty Pancreas and Incidence of Type 2 Diabetes: 5-Year Japanese Cohort Study.
Yamazaki H; Tsuboya T; Katanuma A; Kodama Y; Tauchi S; Dohke M; Maguchi H
Diabetes Care; 2016 Oct; 39(10):1677-83. PubMed ID: 27422578
[TBL] [Abstract][Full Text] [Related]
5. In New-Onset Diabetes Mellitus, Metformin Reduces Fat Accumulation in the Liver, But Not in the Pancreas or Pericardium.
Zsóri G; Illés D; Ivány E; Kosár K; Holzinger G; Tajti M; Pálinkás E; Szabovik G; Nagy A; Palkó A; Czakó L
Metab Syndr Relat Disord; 2019 Jun; 17(5):289-295. PubMed ID: 31013454
[No Abstract] [Full Text] [Related]
6. Longitudinal association of fatty pancreas with the incidence of type-2 diabetes in lean individuals: a 6-year computed tomography-based cohort study.
Yamazaki H; Tauchi S; Wang J; Dohke M; Hanawa N; Kodama Y; Katanuma A; Saisho Y; Kamitani T; Fukuhara S; Yamamoto Y
J Gastroenterol; 2020 Jul; 55(7):712-721. PubMed ID: 32246380
[TBL] [Abstract][Full Text] [Related]
7. Increased Pancreatic Echogenicity with US: Relationship to Glycemic Progression and Incident Diabetes.
Hung CS; Tseng PH; Tu CH; Chen CC; Liao WC; Lee YC; Chiu HM; Lin HJ; Yang WS; Chen MF; Wu MS
Radiology; 2018 Jun; 287(3):853-863. PubMed ID: 29613841
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China.
Weng S; Zhou J; Chen X; Sun Y; Mao Z; Chai K
Medicine (Baltimore); 2018 Jun; 97(26):e11293. PubMed ID: 29953011
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes: Does pancreatic fat really matter?
Guglielmi V; Sbraccia P
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 28984071
[TBL] [Abstract][Full Text] [Related]
10. Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease.
Catanzaro R; Cuffari B; Italia A; Marotta F
World J Gastroenterol; 2016 Sep; 22(34):7660-75. PubMed ID: 27678349
[TBL] [Abstract][Full Text] [Related]
11. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the degree of abdominal myosteatosis by magnetic resonance imaging in subjects with diabetes, prediabetes and healthy controls from the general population.
Kiefer LS; Fabian J; Rospleszcz S; Lorbeer R; Machann J; Storz C; Kraus MS; Schlett CL; Roemer F; Wintermeyer E; Rathmann W; Nikolaou K; Peters A; Bamberg F
Eur J Radiol; 2018 Aug; 105():261-268. PubMed ID: 30017292
[TBL] [Abstract][Full Text] [Related]
13. [Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)].
Jermendy G
Orv Hetil; 2022 Oct; 163(44):1735-1742. PubMed ID: 36309887
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study.
Lesmana CR; Pakasi LS; Inggriani S; Aidawati ML; Lesmana LA
BMC Gastroenterol; 2015 Dec; 15():174. PubMed ID: 26652175
[TBL] [Abstract][Full Text] [Related]
15. Environmental Factors Slightly Outweigh Genetic Influences in the Development of Pancreatic Lipid Accumulation: A Classical Twin Study.
Jermendy G; Kolossváry M; Drobni Z; Papp S; Jermendy ÁL; Panajotu A; Dudás I; Tárnoki ÁD; Tárnoki DL; Voros S; Merkely B; Maurovich-Horvat P
Metab Syndr Relat Disord; 2020 Nov; 18(9):413-418. PubMed ID: 32721180
[No Abstract] [Full Text] [Related]
16. Transabdominal ultrasonography of the pancreas is superior to that of the liver for detection of ectopic fat deposits resulting from metabolic syndrome.
Li S; Su L; Lv G; Zhao W; Chen J
Medicine (Baltimore); 2017 Sep; 96(37):e8060. PubMed ID: 28906401
[TBL] [Abstract][Full Text] [Related]
17. Right heart mechanics in untreated normotensive patients with prediabetes and type 2 diabetes mellitus: a two- and three-dimensional echocardiographic study.
Tadic M; Celic V; Cuspidi C; Ilic S; Pencic B; Radojkovic J; Ivanovic B; Stanisavljevic D; Kocabay G; Marjanovic T
J Am Soc Echocardiogr; 2015 Mar; 28(3):317-27. PubMed ID: 25560484
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic and hepatobiliary manifestations of nonalcoholic fatty pancreatic disease: a referral multi-center experience.
Sbeit W; Greener T; Kadah A; Mari A; Goldin E; Mahamid M; Khoury T
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e297-e301. PubMed ID: 33600093
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic fat content by magnetic resonance imaging in subjects with prediabetes, diabetes, and controls from a general population without cardiovascular disease.
Heber SD; Hetterich H; Lorbeer R; Bayerl C; Machann J; Auweter S; Storz C; Schlett CL; Nikolaou K; Reiser M; Peters A; Bamberg F
PLoS One; 2017; 12(5):e0177154. PubMed ID: 28520813
[TBL] [Abstract][Full Text] [Related]
20. Impact of non-alcoholic fatty pancreas disease on glucose metabolism.
Yu TY; Wang CY
J Diabetes Investig; 2017 Nov; 8(6):735-747. PubMed ID: 28371475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
